NEWS RELEASE - PRESSEMITTEILUNG

Cancellation of the remaining publicly held registered shares of Acino Holding AG Aesch, July 7, 2014, 07.00 hrs - With decision dated June 26, 2014, the Cantonal court of Basel-Landschaft has admitted the claim of Pharma Strategy Partners GmbH, Aesch, for the cancellation of the remaining publicly held shares of Acino Holding AG with a par value of CHF 0.40 each. The decision has not yet become final and enforceable and may be appealed by the parties with the Federal Supreme Court.

The delisting - which has been approved by SIX Swiss Exchange (SIX) on December 20,

2013 - will take place as soon as the decision of the Cantonal court of Basel-Landschaft becomes final and enforceable.

About Acino


Acino (SIX: ACIN), a Swiss-based pharmaceutical company, develops, manufactures and internationally markets well-proven and innovative pharmaceuticals in novel drug delivery forms. Acino is a leader in advanced drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. As a partner of pharmaceutical companies worldwide, Acino supplies finished in-house developed products and/or provides customized one-stop solutions from product development and registration to contract manufacturing, packaging and logistics. Under the brand "Acino Switzerland", Acino markets Swiss-quality medicines in up and coming economies, currently 80 countries in the Middle East, Africa, Latin America and Asia. The Acino Group is headquartered in Aesch BL.
On December 12, 2013, Pharma Strategy Partners GmbH, a wholly-owned subsidiary of Avista Capital Partners and Nordic Capital, successfully completed its public tender offer for Acino Holding AG. Pharma Strategy Partners GmbH intends to effect a full takeover of Acino, and will delist the Acino shares from the stock exchange.

Contact


Robert Schmid
Media & Investor Relations
Phone +41 61 338 61 15 robert.schmid@acino-pharma.com

Acino Holding AG

Dornacherstrasse 114

CH-4147 Aesch

Phone +41 61 338 60 00

Fax +41 61 338 60 80 www.acino-pharma.com

distributed by